Repros Therapeutics Inc. (NASDAQ:RPRX) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.

On December 19, 2016, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit 99.1. Press release dated December 19, 2016

About Repros Therapeutics Inc. (NASDAQ:RPRX)